Research & Innovation Centers

Unlocking the Power of Research & Innovation

Ventas is the leading owner of university-based Research & Innovation (R&I) real estate. With demand in the $140+ billion life science real estate market expected to rise to more than $170 billion within five years,1 the R&I portfolio is a top capital allocation priority.

Ventas now owns or has investments in a R&I portfolio:

  • Containing over seven million square feet and spanning 39 operating properties.
  • Including a presence in the top two life science clusters, San Francisco and Cambridge, MA.
  • Residing on the campuses of over 15 top-tier research universities, including University of Pennsylvania, Yale University, Washington University in St Louis, Duke University and Brown University, collectively ranking in the top 5 percent of all NIH funding and conducting over 10 percent of all university life science research and development in the nation.
  • Expanding with four new properties, consisting of nearly 1.5 million additional square feet, currently under development with three leading research institutions: the University of Pittsburgh, Arizona State University and Drexel University.

4210 Duncan
St. Louis

College of Nursing and Health Professions
Philadelphia

ONE uCity
Philadelphia

Shadyside
Pittsburgh

Our university-based R&I portfolio accounts for 10% of all university-R&D spending in the U.S.

 

Duke University
Arizona State University
Brown University
Drexel University
Illinois Institute of Technology
Old Dominion University
Penn State University
University of Maryland Baltimore
University of Miami
University of Pennsylvania
Virginia Commonwealth University
Wake Forest University
Washington State University in St. Louis
Yale University
University of Pittsburgh

Spurring Life-Changing Innovation through Vibrant Knowledge Communities

Cortex Innovation Community
Saint Louis, MO

Downtown Crossing
New Haven, CT

Univ. of Miami
Life Sci. & Tech. Park
Miami, FL

Providence Innovation & Design District
Providence, RI

 

Data per Q1 2019 filings, press release, supplemental and earnings conference call dated 04/26/2019.

The Ventas Team

Research & Innovation

blue cta

Will Germain

Senior Investment Officer
Research & Innovation

blue cta

Tim Sanders

Senior Investment Officer
Research & Innovation

blue cta

James E. (Jim) Mendelson

Senior Vice President, Asset Management (Office)

1: Source: JLL Research; Life Sciences Industry Trend & Outlook.